VivoPower PLC (VIVO)

Meridian Bioscience Inc. (VIVO) is a life sciences company that develops, manufactures, and distributes diagnostic test kits and related products for the detection and monitoring of infectious diseases, gastrointestinal infections, and other medical conditions. The company's products are used in hospitals, clinical laboratories, and research institutions worldwide. Meridian Bioscience is headquartered in Cincinnati, Ohio and has operations in the United States and other countries.

Meridian Bioscience is focused on expanding its product offerings and increasing its market share in its core markets. The company is also exploring new markets and applications for its products, particularly in the point-of-care and companion diagnostics markets.

Investing in VIVO carries risks, including risks associated with changes in technology and customer preferences, as well as risks associated with competition and market conditions. Additionally, Meridian Bioscience is subject to regulatory and geopolitical risks, which could impact its financial performance.